Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 113

Sort by

Sort Order Select

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Kristin A. Shimano, MD, Rachael F. Grace, MD, Carolyn M. Bennett, MDMSc, Robert J Klaassen, MD FRCPC, Cindy Neunert, MD, Ellis J. Neufeld, MD, Clement Ma, PhD, Wendy B. London, PhD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 2369.

https://doi.org/10.1182/blood-2019-125487

Published: 2019

Journal Articles

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Makoto Hirokawa, MD PhD, Junki Kohmaru, Souichi Koyota, PhD, Keiji Kuba, MD, Naohito Fujishima, MD, Tomoo Saga, MD, Ayumi Omokawa, MD, Shigeharu Ueki, MD, Fumihiro Ishida, MD FACP, Shinji Nakao, MD PhD, Akira Matsuda, MD, Akiko Ohta, MD, Kaoru Tohyama, MD, Ryuji Suzuki, DVM, PhD, Kinuko Mitani, MD

Blood (2018) 132 (Supplement 1): 3858.

https://doi.org/10.1182/blood-2018-99-113262

Published: 2018

Journal Articles

Importance of Complete Parenteral Iron Replacement on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD

Blood (2018) 132 (Supplement 1): 2275.

https://doi.org/10.1182/blood-2018-99-113377

Published: 2018

Journal Articles

Analysis of Elderly Patients with Chronic Myeloid Leukemia

Engin Kelkitli, MD, Hakan Goker, MD, Mehmet Turgut, MD, Memis Hilmi Atay, MD

Blood (2018) 132 (Supplement 1): 5449.

https://doi.org/10.1182/blood-2018-99-110222

Published: 2018

Journal Articles

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Chunlin Qian, PhD, Winghan Jacqueline Kwong, PhD PharmD

Blood (2017) 130 (Supplement 1): 2087.

https://doi.org/10.1182/blood.V130.Suppl_1.2087.2087

Published: 2017

Journal Articles

Lck Is a Crucial Anergy Regulator in CLL

Alexander Fuchs, Melanie Märklin, PhD, Jonas Heitmann, Felicia Truckenmüller, Sebastian Jonas Saur, MD, Manuela Ganser, Stefanie Bugl, Ursula Kohlhofer, Leticia Quintanilla-Martinez, MD, Hans-Georg Kopp, MD, Lothar Kanz, Anjana Rao, PhD, Stefan Wirths, MD, Martin R. Mueller, MD PhD

Blood (2017) 130 (Supplement 1): 3003.

https://doi.org/10.1182/blood.V130.Suppl_1.3003.3003

Published: 2017

Journal Articles

BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Blood (2017) 130 (Supplement 1): 3004.

https://doi.org/10.1182/blood.V130.Suppl_1.3004.3004

Published: 2017

Journal Articles

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Kah-Whye Peng, PhD, Linh Pham, Lianwen Zhang, PhD, Rebecca Nace, Nathan Jenks, Michael Steele, Alysha Newsom, Ronald Marler, DVM, PhD, Martha Q Lacy, MD, Stephen J. Russell, MD PhD

Blood (2017) 130 (Supplement 1): 1807.

https://doi.org/10.1182/blood.V130.Suppl_1.1807.1807

Published: 2017

Journal Articles

Nucleolin As a Survival Predictor in Acute Lymphoblastic Leukemia and Its Promotion to Drug Resistance By ERK Pathway

Jianda Hu, Prof MDPhD, Yanxin Chen, MDPhD, Minhui Lin, PhD, Yingyu Chen, PhD, Ting Yang

Blood (2017) 130 (Supplement 1): 1291.

https://doi.org/10.1182/blood.V130.Suppl_1.1291.1291

Published: 2017

Journal Articles

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

Leendert Porcelijn, Elly Huiskes, Martin Schipperus, Bronno van der Holt, Masja de Haas, Jaap Jan Zwaginga

Blood (2017) 129 (25): 3389–3391.

https://doi.org/10.1182/blood-2016-11-751719

Published: 2017

Includes: Supplemental data

Journal Articles

A Prospective Evaluation of Neurocognitive Function and Neurologic Symptoms in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Undergoing Anti-CD22 Chimeric Antigen Receptor Therapy

Haneen Shalabi, DO, Pamela L Wolters, PhD, Staci Martin, PhD, Cindy Delbrook, RN, Bonnie Yates, RN, PNP, Daniel W. Lee, III, MD, Crystal L. Mackall, MD, Terry J Fry, MD, Nirali N Shah, MD

Blood (2016) 128 (22): 1625.

https://doi.org/10.1182/blood.V128.22.1625.1625

Published: 2016

Journal Articles

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

Alessandro Lagana, PhD, Deepak Perumal, PhD, David Melnekoff, BS, Ben Readhead, MBBS, Brian Kidd, PhD, Violetta V Leshchenko, PhD, Pei-Yu Kuo, MS, Jonathan J Keats, PhD, Mary Derome, MS, Jennifer Yesil, MS, Daniel Auclair, PhD, Deepu Madduri, Ajai Chari, MD, Hearn Jay Cho, MD PhD, Bart Barlogie, MD PhD, Sundar Jagannath, MD, Joel Dudley, PhD, Samir Parekh, MD

Blood (2016) 128 (22): 3285.

https://doi.org/10.1182/blood.V128.22.3285.3285

Published: 2016

Journal Articles

Efficacy of Second Line Agents Dapsone & Azathioprine in Children & Adults with Immune Thrombocytopenia: Single Centre Experience from India

Venkatesh Shreeganesh Ekbote, DM, Biju George, DM, Vikram Mathews, DM, Kavitha Lakshmi, MSc, Abhijeet Ganapule, DM, Fausia N Abubacker, DM, Anu Korula, MD DM, Alok Srivastava, MD FRACP

Blood (2015) 126 (23): 1064.

https://doi.org/10.1182/blood.V126.23.1064.1064

Published: 2015

Journal Articles

Genetic Loss of NFAT2 Leads to CLL Transformation

Melanie Märklin, PhD, Jonas Heitmann, Felicia Truckenmüller, Lothar Kanz, MD, Sebastian Jonas Saur, MD, Manuela Ganser, Bugl Stefanie, PhD, Hans-Georg Kopp, MD, Michael Haap, MD, Anjana Rao, PhD, Stefan Wirths, MD, Martin R Mueller, MD PhD

Blood (2015) 126 (23): 364.

https://doi.org/10.1182/blood.V126.23.364.364

Published: 2015

Journal Articles

Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

Beth A Christian, MD, John G. Kuruvilla, MD, Sonali M. Smith, MD, Pierluigi Porcu, MD, Kami J. Maddocks, MD, Amy S. Ruppert, MAS, John C Byrd, MD, Michael R. Grever, MD, Kristie A. Blum, MD

Blood (2015) 126 (23): 3983.

https://doi.org/10.1182/blood.V126.23.3983.3983

Published: 2015

Journal Articles

Granulocyte Transfusions at Appropriate Doses Improve Survival in Hematological Patients with Febrile Neutropenia

Luciana Teofili, Caterina Giovanna Valentini, Nicola Piccirillo, Roberta De Blasi, Patrizia Chiusolo, Rossana Putzulu, Stefan Hohaus, Marco Lai, Luana Fianchi, Maria Bianchi, Gina Zini, Simona Sica, Livio Pagano

Blood (2015) 126 (23): 3566.

https://doi.org/10.1182/blood.V126.23.3566.3566

Published: 2015

Journal Articles

Long Term Efficacy, Safety and Tolerability (>24 Months) of Twice Daily Dosing of Deferasirox in Transfusion Dependent Thalassemias Who Were Unresponsive to Standard Once Daily Dose

Bunchoo Pongtanakul, MD, Vip Viprakasit, Dr.

Blood (2015) 126 (23): 958.

https://doi.org/10.1182/blood.V126.23.958.958

Published: 2015

Journal Articles

Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study

Aristoteles Giagounidis, MD PhD, Uwe Platzbecker, MD, Ulrich Germing, MD, Katharina Götze, MD, Philipp Kiewe, MD, Karin Tina Mayer, MD, Oliver Ottmann, MD, Markus Radsak, MD, Thomas Wolff, MD, Detlef Haase, MD, Monty Hankin, Dawn Wilson, Xiaosha Zhang, Adberrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD

Blood (2015) 126 (23): 92.

https://doi.org/10.1182/blood.V126.23.92.92

Published: 2015

Journal Articles

Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study

Uwe Platzbecker, MD, Ulrich Germing, MD, Aristoteles Giagounidis, MD PhD, Katharina Götze, MD, Philipp Kiewe, MD, Karin Tina Mayer, MD, Oliver Ottmann, MD, Markus Radsak, MD, Thomas Wolff, MD, Detlef Haase, MD, Monty Hankin, Dawn Wilson, Xiaosha Zhang, Abderrahmane Laadem, MD, Matthew L. Sherman, MD, Kenneth M. Attie, MD

Blood (2015) 126 (23): 2862.

https://doi.org/10.1182/blood.V126.23.2862.2862

Published: 2015

NARROW

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children

Somatic Mutations of Myeloid Malignancy-Associated Genes in Acquired Pure Red Cell Aplasia in Adults

Importance of Complete Parenteral Iron Replacement on Hemoglobin Normalization: A Retrospective Analysis

Analysis of Elderly Patients with Chronic Myeloid Leukemia

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Lck Is a Crucial Anergy Regulator in CLL

BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Ruxolitinib Rescues Mice from Lethal Interferon Beta Toxicity and TLS

Nucleolin As a Survival Predictor in Acute Lymphoblastic Leukemia and Its Promotion to Drug Resistance By ERK Pathway

Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

A Prospective Evaluation of Neurocognitive Function and Neurologic Symptoms in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Undergoing Anti-CD22 Chimeric Antigen Receptor Therapy

Integrative Network Analysis of Newly Diagnosed Multiple Myeloma Identifies a Novel RNA-Seq Based High Riskgene Signature

Efficacy of Second Line Agents Dapsone & Azathioprine in Children & Adults with Immune Thrombocytopenia: Single Centre Experience from India

Genetic Loss of NFAT2 Leads to CLL Transformation

Updated Results of a Phase I Study of Ibrutinib and Lenalidomide in Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma

Granulocyte Transfusions at Appropriate Doses Improve Survival in Hematological Patients with Febrile Neutropenia

Long Term Efficacy, Safety and Tolerability (>24 Months) of Twice Daily Dosing of Deferasirox in Transfusion Dependent Thalassemias Who Were Unresponsive to Standard Once Daily Dose

Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study

Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only